KRAS and pancreatic ductal adenocarcinoma: The PI3K and MAPK pathways are two prominent mitogenic pathways driving pancreatic ductal adenocarcinoma (PDAC), in part due to the constitutive activation of KRAS, which is mutated in almost all PDAC [5,6,7,8].